 |
SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...
With many Aussies now working from home due to Government-mandated restrictions, there may be concerns that staying home could be driving up energy ...
While owning a home is frequently viewed as a symbol of stability, independence, and success, this may only be true for some. When it comes to a lim...
When you're looking to grow your business, hiring a digital marketing agency can be a great way to get started before hiring in-house. You can also ...
Being a new business owner can be an overwhelming experience for most due to the hefty responsibility of keeping a startup afloat. As such, many peo...
Good service is the key to success within any customer-facing business. Employees should strive to help in a clear and friendly way, to attract new ...
Valuation of and is done to determine its value based on various factors. The valuation is carried out using sales, income, cost, and market data...